Consolidated statement of profit or loss and other comprehensive income

FOR THE YEAR ENDED 30 SEPTEMBER 2019

	Notes		2019  R’m		2018  R’m
Revenue	2		25 672		23 488
Other income	2		232		228
Drugs and consumables			(5 311)		(5 062)
Employee benefits expense	3		(8 860)		(8 064)
Retirement benefit asset and post-employment medical aid income			39		34
Depreciation on property, plant and equipment			(1 236)		(1 133)
Amortisation of intangible assets			(586)		(537)
Repairs and maintenance expenditure on property, plant and equipment			(540)		(529)
Occupational expenses			(971)		(829)
Hospital service expenses			(838)		(786)
Communication expenses			(365)		(399)
Radiology service costs			(1 376)		(1 033)
Professional, legal and secretarial fees			(582)		(292)
Provision for expected credit losses (2018: provision for impairment of receivables)			(19)		(33)
Other expenses			(1 315)		(1 205)
Operating profit			3 944		3 848
Fair value adjustments to contingent consideration			2		(18)
Fair value (loss)/profit on derivative financial instruments	4		(438)		127
Gain on derecognition of lease assets and liabilities			–		79
Impairment of assets and investments	10 and 11		(164)		(34)
Profit on disposal of investment in joint venture	26		1 501		–
Profit on disposal of investment in subsidiary	26		11		–
Profit on disposal of property, plant and equipment			–		35
Transaction costs relating to acquisitions and disposals			(148)		(38)
Other			(22)		(95)
Finance income	5		60		40
Finance cost	5		(1 058)		(1 002)
Share of associates' and joint ventures' net profit/(loss) after tax	12		18		(105)
Profit before tax	6		3 706		2 837
Tax expense	7		(835)		(923)
Profit after tax			2 871		1 914
Other comprehensive income/(loss), net of tax
Items that may be reclassified to profit or loss
Movement in foreign currency translation reserve			117		183
Items that may not be reclassified to profit or loss
Retirement benefit asset and post-employment medical aid			(54)		–
Total comprehensive income for the year			2 934		2 097
Profit after tax attributable to:
Ordinary equity holders of the parent			2 569		1 575
Non-controlling interest			302		339
			2 871		1 914
Total comprehensive income attributable to:
Ordinary equity holders of the parent			2 622		1 757
Non-controlling interest			312		340
			2 934		2 097
Earnings per share (cents)	8		176.4		108.6
Diluted earnings per share (cents)	8		175.8		108.1

The accompanying notes are an integral part of these consolidated financial statements.